Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-006 · synthetic case TESTO-FX-04

Secondary pattern with obesity and diabetes

LH 1.2 and FSH 2.0 with BMI 36.

Synthetic · no real patientAuthored by Biod · reviewed by Dr. AmaralTestosterone engine v1.0.0

Purpose: LH 1.2 and FSH 2.0 with BMI 36.

Inputs the engine received

Testosterone and hormones

Total testosterone, sample 1
180 ng/dL
Total testosterone, sample 2 (separate day)
170 ng/dL
SHBG
18 nmol/L
LH
1.2 IU/L
FSH
2 IU/L
Prolactin
12 ng/mL

Symptoms and findings

Age
46 years
Erectile dysfunction
Yes
Fatigue
Yes

Possible reversible contributors

BMI
36 kg/m²
Diabetes or prediabetes
Yes

What the engine reports

Detected clinical pattern

Criteria for Testosterone Deficiency Met

Symptoms with low total testosterone on two samples (180 and 170 ng/dL). Secondary pattern. The cause still has to be found.

  • Axis: Secondary (hypogonadotropic) pattern

Why this pattern was identified

  • Low testosterone on two samples. 180 and 170 ng/dL are both below 300 ng/dL (AUA). With compatible symptoms, the criteria for testosterone deficiency are met.
  • Secondary pattern. LH 1.2 IU/L is not elevated despite low testosterone: the problem is above the testes (hypothalamus or pituitary) or functional.

Calculations

Calculated free testosterone (Vermeulen)
4.6 ng/dL

No threshold is applied: cutoffs are assay-specific.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Address the contributor(s) (BMI 36; diabetes or prediabetes) and repeat testosterone.Endocrine Society 2018.

Differentials, pitfalls and contradicting signals

  • Functional suppression (obesity, opioids, illness) and pituitary disease look alike on these values.
Evidence and rule trace · 4 rules

HG-CALC-01Calculated free testosterone

Inputs: total testosterone 180 ng/dL · SHBG 18 nmol/L · albumin 4.3 g/dL

Calculated free testosterone 4.6 ng/dL.

HG-03Low testosterone confirmed on two samples

Inputs: 180 ng/dL · 170 ng/dL

Biochemically low testosterone on two samples.

HG-06Secondary (hypogonadotropic) pattern

Inputs: LH 1.2 IU/L (upper limit 9) · total testosterone 180 ng/dL

Pattern of secondary (hypogonadotropic) hypogonadism.

HG-08Reversible contributors present

Inputs: low testosterone · BMI 36 · diabetes or prediabetes

Reversible contributors are present.

Evidence

  • EV-ES-TRT-2018 · Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
  • EV-AUA-2018 · Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432.
  • EV-TRAVISON-2017 · Travison TG, Vesper HW, Orwoll E, et al. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102(4):1161-1173.
  • EV-VERMEULEN-1999 · Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672.

Physician adjudication required. Clinical decision support for physician review. This output identifies laboratory patterns and cautions. It does not diagnose, find the cause, or recommend starting, stopping or dosing testosterone therapy. Physician adjudication is required.

Change the values

The same engine, starting from this case. Change any value and watch the pattern and the rule trace react.

Against typical adult male reference intervals

Total testosterone (sample 1)180 ng/dL · below reference
ref 3001000
LH1.2 IU/L · below reference
ref 1.79
Prolactin12 ng/mL · within reference
ref 420
Testosterone and hormones
  • <264
  • 264–299
  • 300–350 borderline
  • >350

4.3 g/dL is assumed when left empty.

Symptoms and findings
Possible reversible contributors
Testosterone therapy context

Live result · computed in your browser

Detected clinical pattern

Criteria for Testosterone Deficiency Met

Symptoms with low total testosterone on two samples (180 and 170 ng/dL). Secondary pattern. The cause still has to be found.

  • Axis: Secondary (hypogonadotropic) pattern

Why this pattern was identified

  • Low testosterone on two samples. 180 and 170 ng/dL are both below 300 ng/dL (AUA). With compatible symptoms, the criteria for testosterone deficiency are met.
  • Secondary pattern. LH 1.2 IU/L is not elevated despite low testosterone: the problem is above the testes (hypothalamus or pituitary) or functional.

Calculations

Calculated free testosterone (Vermeulen)
4.6 ng/dL

No threshold is applied: cutoffs are assay-specific.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Address the contributor(s) (BMI 36; diabetes or prediabetes) and repeat testosterone.Endocrine Society 2018.

Differentials, pitfalls and contradicting signals

  • Functional suppression (obesity, opioids, illness) and pituitary disease look alike on these values.
Evidence and rule trace · 4 rules

HG-CALC-01Calculated free testosterone

Inputs: total testosterone 180 ng/dL · SHBG 18 nmol/L · albumin 4.3 g/dL

Calculated free testosterone 4.6 ng/dL.

HG-03Low testosterone confirmed on two samples

Inputs: 180 ng/dL · 170 ng/dL

Biochemically low testosterone on two samples.

HG-06Secondary (hypogonadotropic) pattern

Inputs: LH 1.2 IU/L (upper limit 9) · total testosterone 180 ng/dL

Pattern of secondary (hypogonadotropic) hypogonadism.

HG-08Reversible contributors present

Inputs: low testosterone · BMI 36 · diabetes or prediabetes

Reversible contributors are present.

Evidence

  • EV-ES-TRT-2018 · Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
  • EV-AUA-2018 · Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432.
  • EV-TRAVISON-2017 · Travison TG, Vesper HW, Orwoll E, et al. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102(4):1161-1173.
  • EV-VERMEULEN-1999 · Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672.

Physician adjudication required. Clinical decision support for physician review. This output identifies laboratory patterns and cautions. It does not diagnose, find the cause, or recommend starting, stopping or dosing testosterone therapy. Physician adjudication is required.

More testosterone cases

All testosterone cases

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod